S. Gail Eckhardt was named associate dean for experimental therapeutics and associate director for translational research at Baylor College of Medicine.
Researchers at Baylor College of Medicine and Rice University received a $2.3 million Breakthrough Award from the Department of Defense Congressionally Directed Medical Research Programs to develop a novel NanoGel antibody therapy that targets ER+ breast cancer that has metastasized to bone.
